sun pharma dadra unit: us fda warning letter shows multiple repeat observations | n18v | cnbc tv18
Published 4 days ago • 797 plays • Length 3:03Download video MP4
Download video MP3
Similar videos
-
2:29
us fda finds incomplete lab records for sun pharma's dadra unit
-
1:54
sun pharma slips in trade after receiving a warning letter from the us fda for its dadra facility
-
2:16
sun pharma's halol facility receives u.s. fda warning letter | business lunch | cnbc-tv18
-
2:36
u.s. fda issues warning letter to sun pharma, questions manufacturing practices at halol facility
-
1:18
us fda records 11 observations for sun pharma’s dadra facility
-
5:42
form 483 for sun pharma
-
6:23
exclusive: former ceo of ranbaxy on sun pharma buy out
-
10:56
road ahead for orchid pharma & cipla's partnership to combat uti i md manish dhanuka shares outlook
-
1:32
us fda finds incomplete lab records for sun pharma's dadra unit
-
3:06
sun pharma receives warning letter from us fda for its halol plant
-
2:38
relief for sun pharma: us fda clears sun pharma's dadra unit
-
23:49
us fda issues 6 observation on sun pharma | halftime report | cnbc-tv18
-
3:56
sun pharma news: u.s. fda lists company's halol plant under an import alert | halftime report
-
11:40
sun pharma: us fda's bitter pill. catch all the details on markets today
-
1:55
sun pharma mohali unit: u.s. fda flags compliance concerns | halftime report | cnbc-tv18
-
5:10
vishal manchanda on impact of u.s fda oai status on sun pharma | bazaar open exchange | cnbc-tv18
-
1:15
us fda classifies the inspection at- sun pharma's dadra unit as oai, stock under pressure
-
2:13
us fda woes haunt sun pharma?
-
2:25
us fda issues 3 observations to lupin’s pithampur unit 3
-
23:34
sun pharma in focus | us fda to re-inspect halol unit | movers & shakers | cnbc tv18
-
2:47
sun pharma halol plant | us fda issues 3 observations in form 483 | cnbc tv18
-
3:01
why indian pharma companies won't panic as u.s fda scrutiny makes a comeback | midcap radar